5. EQUITY TRANSACTIONS (Details - Warrant activity) - Warrants [Member] - $ / shares |
12 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Warrants outstanding, beginning balance | 2,021,368 | 342,992 |
Warrants granted | 0 | 4,432,585 |
Adjustment for reverse split | 0 | 73 |
Warrants exercised | 0 | (2,700,000) |
Warrants cancelled/forfeited | (29,395) | (54,282) |
Warrants outstanding, ending balance | 1,991,973 | 2,021,368 |
Warrants exercisable | 1,991,973 | 2,021,368 |
Outstanding, Weighted Average Exercise Price | $ 5.21 | $ 27 |
Granted, Weighted Average Exercise Price | 1.79 | |
Exercised, Weighted Average Exercise Price | 1.5 | |
Cancelled/Forfeited, Weighted Average Exercise Price | 91.17 | 91.23 |
Outstanding Weighted Average Exercise Price | 5.23 | 5.21 |
Exercisable, Weighted Average Exercise Price | 5.23 | 5.21 |
Warrants Weighted average estimated fair value of warrants granted | $ 1.22 |
X | ||||||||||
- Definition Adjustment for reverse split No definition available.
|
X | ||||||||||
- Definition Warrants exercisable No definition available.
|
X | ||||||||||
- Definition Warrants Exercisable, Weighted Average Exercise Price No definition available.
|
X | ||||||||||
- Definition Warrants granted No definition available.
|
X | ||||||||||
- Definition Warrants Weighted average estimated fair value of warrants granted No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|